Full-Time

Sterile Processing Technician 4 – Team Lead

Memorial Hermann

Memorial Hermann

10,001+ employees

Integrated health system delivering patient-centered care

No salary listed

Humble, TX, USA

In Person

On-call weekends are required every six weeks.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Infection Control
Inventory Management

Get referred to Memorial Hermann

See people who can refer or advise you

Requirements
  • A high school diploma or GED is required.
  • Certification by the Certification Board for Sterile Processing and Distribution or the International Association of Healthcare Central Service Materiel Management is required, or the certifications must be acquired within one year of hire.
  • Certified Instrument Specialist and Certified Healthcare Leader, or Certified in Sterile Processing Management and Surgical Instrument Specialist Certification, are required, or the certifications must be acquired within one year of hire.
  • A minimum of three years of experience involving sterilization of instruments, equipment, and supplies is required.
  • Ability to follow oral and written instructions in English is required.
  • Ability to perform basic mathematical calculations is required.
  • Ability to lift or maneuver supplies and equipment with others is required.
  • Advanced computer skills and knowledge of Sterile Processing Information Systems are required.
  • Ability to think critically and strategically during work is required.
  • Advanced problem-solving skills are required.
  • Effective oral and written communication skills are required.
  • Advanced leadership, coaching, and mentorship skills in a team environment are required.
  • Ability to maintain composure and a professional demeanor during tense or stressful situations is required.
Responsibilities
  • Mentor, train, and schedule the work of employees in the Sterile Processing department.
  • Assist in supervising, coaching, mentoring, leading, and training department personnel using Standard Precautions and Event-Related Sterility principles.
  • Troubleshoot problems and strategically resolve issues within the Sterile Processing department.
  • Train and mentor Sterile Processing Technicians.
  • Prepare work schedules, assist the manager with performance issues, and provide input on performance evaluations.
  • Ensure accurate and appropriate handling of instruments and equipment, including selecting cleaning agents and lubricants, examining instruments for function, identifying and assembling instruments according to count sheets, and preparing them for sterilization.
  • Train and prepare team members regarding hospital and medical facility sterilization standards.
  • Load, monitor, operate, and maintain cleaning and sterilization equipment and machinery safely and accurately.
  • Monitor supplies and materials inventory.
  • Complete quality-control and infection-control standards checks as needed.
  • Communicate delays and supply, instrumentation, equipment, and substitution problems involving the Operating Room and other areas.
  • Accept and complete the most complex assignments.
  • Ensure safe care for patients, staff, and visitors while adhering to organizational policies, procedures, standards, budget, time-management, supply-management, productivity, and service-quality requirements.
  • Support individual professional growth and development by meeting mandatory and continuing-education and skills-competency requirements.
  • Support department-based goals, and serve as a preceptor, mentor, and resource to less experienced staff.
  • Model service standards by providing safe, caring, personalized, and efficient experiences to patients and colleagues.
Desired Qualifications
  • A minimum of one year of leadership or management experience is preferred.

Memorial Hermann Health System is a nonprofit, community-owned health system serving the Greater Houston area with more than 260 care delivery sites. It delivers safe, high-quality, patient-centered care through an integrated network that combines clinical expertise with advanced technology. The system differentiates itself through its community ownership, value-driven culture, and broad network of hospitals, clinics, and specialty services. Its goal is to improve regional health outcomes by providing comprehensive, accessible care and leveraging innovation to personalize treatment.

Company Size

10,001+

Company Stage

Grant

Total Funding

$5M

Headquarters

Houston, Texas

Founded

1907

Get referred to Memorial Hermann

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 16, 2026 Helix Genomic Advantage gives employees clinical genomic screening and targeted care.
  • June 2026 Texas funded Memorial Hermann $750,000 to add a second mobile stroke unit.
  • HEAL High School reopened August 2026 with simulated hospital training and paid apprenticeships.

What critics are saying

  • Memorial Hermann will terminate commercial health plans by end-2027 after solvency concerns.
  • Federal prosecutors indicted transplant director John Bynon in February 2026; families still sue.
  • The September 2025 hidden-camera class action threatens reputation and trial expenses in 2026.

What makes Memorial Hermann unique

  • Memorial Hermann pioneered America’s first mobile stroke unit in 2014, now expanding it in 2026.
  • TIRR Memorial Hermann ranked No. 1 Texas rehabilitation hospital in 2026-2027 U.S. News.
  • GenoME and Helix Genomic Advantage embed population genomics into workforce care and research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Wellness Program

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

14%

1 year growth

14%

2 year growth

14%
The Business Journals
Aug 19th, 2026
Former Houston transplant surgeon's federal case moves toward trial.

Former Houston transplant surgeon's federal case moves toward trial. By Megan Reyna - KHOU 11 Aug 19, 2026 Preview this article 1 min Dr. John Stevenson Bynon, 66, the former surgical director of liver transplantation at Memorial Hermann, is accused of falsifying medical records. Don't Stop Here - Continue Reading For $1 Per Week Secure 4 weeks of award-winning news and trusted insights Subscribe for only $4

AllSci
Jul 8th, 2026
Helix secures AstraZeneca partnership to power drug discovery with US genomic data.

Helix secures AstraZeneca partnership to power drug discovery with US genomic data. July 8, 2026 AstraZeneca has signed a multi-year agreement with San Mateo-based Helix to access its GenoSphere clinico-genomic cohort platform for drug discovery and development, adding a major US commercial data source to its existing population genomics infrastructure. The deal gives AstraZeneca (Nasdaq: AZN) access to Helix's continuously growing, deeply phenotyped cohorts spanning cardiometabolic, respiratory, and autoimmune disease areas. The agreement is AstraZeneca's latest move in a systematic multi-source genomics strategy and arrives as Helix establishes itself as a recurring platform partner to top-tier pharma. Financial terms were not disclosed. GenoSphere cohorts combine Exome+ genomic sequencing with longitudinal electronic health record data averaging 13 years of follow-up per patient, drawn from the Helix Research Network - described by the company as the largest precision health network in North America. The datasets are de-identified and fully consented, with the option to launch targeted follow-on studies. The platform is designed to support target identification, disease biology research, and patient stratification across the drug development lifecycle, functioning as a discovery infrastructure layer rather than a single-indication tool. Helix recently launched its Genomic Advantage program with Nebraska Medicine and Memorial Hermann Health System, adding new health system partners that feed the underlying research network. For AstraZeneca, the Helix deal adds a commercially managed, US-based, exome-sequenced cohort to a genomics portfolio that already includes co-funded access to the UK Biobank whole-genome sequencing dataset and membership in the Alliance for Genomic Discovery - a consortium that includes AbbVie, Amgen, GSK, Merck, and Novo Nordisk, among others. AstraZeneca's Centre for Genomics Research has publicly stated a goal of analyzing 2 million genomes by 2026. The Helix agreement adds a North American commercial data layer to AstraZeneca's existing European biobank partnerships. Helix previously signed a multi-year collaboration with GSK, announced in January 2026 using an identical structural template, with AstraZeneca now the third major pharma to sign onto the same GenoSphere platform following Helix's March 2026 agreement with Alnylam Pharmaceuticals. This article was generated with AI assistance and reviewed and edited by the AllSci editorial team Explore more at AllSci News: https://allsci.com/news/

Business Wire
Jun 23rd, 2026
Cadence Raises $100M Series C Led by Spark Capital to Automate Chronic Care

Cadence, the clinical AI company managing chronic care for older adults, announced a $100 million Series C, amid adoption of its AI-powered care model across...

PR Newswire
Jun 16th, 2026
Two US health systems launch Helix Genomic Advantage to cut costs through precision medicine

Nebraska Medicine and Memorial Hermann Health System have launched Helix Genomic Advantage, integrating clinical-grade genomic insights into care delivery for their workforces. The programme follows a similar launch with St. Luke's University Health Network. Both health systems are Helix Research Network partners operating large-scale community genomics studies. The Genomic Advantage model aims to implement precision medicine for targeted populations whilst reducing costs, addressing the high expense that has historically prevented scaling diagnostic genomics. "The high cost of diagnostic genomics has served as a significant barrier, preventing health systems from scaling these insights for patient populations," said James Lu, Helix CEO and co-founder. The programme aligns incentives to drive expanded access and total cost of care reduction across risk-based populations.

McIlroy Insurance Group
Jun 16th, 2026
Memorial Hermann Is Leaving the Houston Market. Here's What Every Business Owner and HR Manager Needs to Know

Memorial Hermann Is Leaving the Houston Market. Here's What Every Business Owner and HR Manager Needs to Know